|
Volumn 36, Issue 10, 2005, Pages 925-926
|
Allogeneic BMT followed by substrate reduction therapy in a child with subacute Tay-Sachs disease [5]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA N ACETYLHEXOSAMINIDASE A;
BUSULFAN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
MIGLUSTAT;
THYMOCYTE ANTIBODY;
VALPROIC ACID;
ALLOGENIC BONE MARROW TRANSPLANTATION;
BRAIN ATROPHY;
BRAIN VENTRICLE;
CASE REPORT;
CHILDHOOD DISEASE;
DETERIORATION;
ELECTROENCEPHALOGRAPHY;
ENZYME ACTIVITY;
EPILEPTIC DISCHARGE;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
HUMAN CELL;
LETTER;
MOTOR PERFORMANCE;
NEUROLOGIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
SEIZURE;
SIDE EFFECT;
SPEECH DISORDER;
SUBARACHNOID SPACE;
TAY SACHS DISEASE;
VISUAL DISORDER;
1-DEOXYNOJIRIMYCIN;
BONE MARROW TRANSPLANTATION;
CHILD;
FEMALE;
HUMANS;
NERVOUS SYSTEM DISEASES;
TAY-SACHS DISEASE;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 27844543404
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/sj.bmt.1705155 Document Type: Letter |
Times cited : (39)
|
References (6)
|